Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Levy, M.D., Ph.D.

Profile Picture

Johns Hopkins Hospital, Baltimore, MDfellowship09/2009Neuroimmunology
Johns Hopkins Hospital, Baltimore, MDresidency06/2008Neurology
Baylor College of Medicine, Houston, TXMD, PhD05/2004Medicine/Neuroscience
Univ of Pennsylvania, Philadelphia, PABA06/1997Biology

Michael Levy, MD, PhD, is an Associate Professor in Neurology who was recently recruited to lead the research unit in the new Division of Neuroimmunology at the Massachusetts General Hospital. His mission is to build a combined clinical and research neuroimmunology program to develop therapies for patients with autoimmune diseases of the central nervous system. Dr. Levy moved from Baltimore, MD, where was on the faculty at Johns Hopkins University since 2009 and Director of the Neuromyelitis Optica Clinic.

Clinically, Dr. Levy specializes in taking care of children and adults with rare neuroimmunological diseases including neuromyelitis optica, transverse myelitis, MOG antibody disease and acute disseminated encephalomyelitis. In addition to four monthly clinics, Dr. Levy is the principal investigator on several clinical studies and drug trials for these conditions. In the laboratory, his research focuses on the development of animal models of neuromyelitis optica with the goal of tolerization as a sustainable long term treatment.

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R43AI157959 (KONG, PHILIP) Sep 1, 2021 - Aug 31, 2022
    Spatiotemporal tuning of myelin antigens and rapamycin for enhanced antigen-specific immune tolerance in multiple sclerosis.
    Role: Co-Principal Investigator
  2. R01AI130548 (LEVY, MICHAEL) May 25, 2018 - Apr 30, 2023
    Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica
    Role: Principal Investigator
  3. K08NS078555 (LEVY, MICHAEL) May 1, 2013 - Apr 30, 2019
    immunopathogenesis of NMO-IgG and AQP4-specific T cells in neuromyelitis optica
    Role: Principal Investigator

Featured Content

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Levy's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (408)
Co-Authors (9)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.